報價延遲最少15分鐘:2025/11/04 18:21 EST
盤後時段
|
||||
|
16.21 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
16.2
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.68/2.41
|
|
企業價值
3.89B
|
| 資產負債 |
|
每股賬面淨值
12.97
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
301.03M
|
|
每股收益
10.56
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/11/04 18:21 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development. |
